{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:17:14Z","timestamp":1791494234902,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20150696"],"award-info":[{"award-number":["BK20150696"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20153810"],"award-info":[{"award-number":["20153810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573484"],"award-info":[{"award-number":["81573484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500179"],"award-info":[{"award-number":["81500179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bbadis.2019.01.020","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T01:48:50Z","timestamp":1547862530000},"page":"1253-1264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6\/STAT3-dependent inflammation"],"prefix":"10.1016","volume":"1865","author":[{"given":"Dandan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangrong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoyu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.01.020_bb0005","series-title":"Molecular Mechanisms of Myocardial Remodeling","author":"Swynghedauw","year":"1999"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For End point reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1749-6632.2009.05084.x","article-title":"Molecular mechanisms in evolutionary cardiology failure","volume":"1188","author":"Swynghedauw","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2018.09.009","article-title":"Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse","volume":"24","author":"Diaz","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"P.C. Group","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.CIR.103.10.1375","article-title":"Mechanotransduction in Cardiomyocyte Hypertrophy","volume":"103","author":"Sugden","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bbadis.2019.01.020_bb0050","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/HJH.0000000000001613","article-title":"Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II\/high-salt-diet-induced hypertension","volume":"36","author":"Yang","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0055","article-title":"Binding of EBP50 to Nox organizing subunit p47phox is pivotal to cellular reactive species generation and altered vascular phenotype","volume":"113","author":"Al","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2016.09.001","article-title":"Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion","volume":"100","author":"Choi","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0065","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/HYPERTENSIONAHA.115.05344","article-title":"Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II","volume":"65","author":"Takayanagi","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/ars.2012.4754","article-title":"The predicted molecular weight of Nrf2: it is what it is not","volume":"18","author":"Lau","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bbadis.2019.01.020_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmet.2018.02.006","article-title":"Synergy between the KEAP1\/NRF2 and PI3K pathways drives non-small-cell lung cancer with an altered immune microenvironment","volume":"27","author":"Best","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97735","article-title":"Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice","volume":"3","author":"Chartoumpekis","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.bbadis.2019.01.020_bb0090","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db17-1087","article-title":"Nrf2-mediated antioxidant defense and peroxiredoxin 6 are linked to biosynthesis of palmitic acid ester of 9-hydroxystearic acid","volume":"67","author":"Kuda","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.yjmcc.2014.04.006","article-title":"Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins","volume":"72","author":"Wang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0100","first-page":"315","article-title":"Up-regulation of p27kip1 contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy","volume":"90","author":"Li","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/HYPERTENSIONAHA.115.06062","article-title":"Nrf2-mediated cardiac maladaptive remodeling and dysfunction in a setting of autophagy insufficiency","volume":"67","author":"Qin","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0110","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1074\/jbc.M211558200","article-title":"Identification of the NF-E2-related Factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0115","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mc.20465","article-title":"Molecular mechanisms of Nrf2-mediated antioxidant response","volume":"48","author":"Li","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0135","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.109.189480","article-title":"Nrf2 protects against maladaptive cardiac responses to hemodynamic stress","volume":"29","author":"Li","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2019.01.020_bb0140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.33549\/physiolres.933403","article-title":"Nrf2 as a key player of redox regulation in cardiovascular diseases","volume":"65","author":"Baran\u010d\u00edk","year":"2016","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.freeradbiomed.2015.10.409","article-title":"Left ventricular diastolic dysfunction in Nrf2 knock out mice Is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function","volume":"89","author":"Erkens","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0150","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2017.10.119","article-title":"Interleukin-6 deficiency attenuates angiotensin II-induced cardiac pathogenesis with increased myocyte hypertrophy","volume":"494","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0155","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jcp.20307","article-title":"Role of interleukin-6 in cardiomyocyte\/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation","volume":"204","author":"Fredj","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0160","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/bbrc.2000.2364","article-title":"Autocrine\/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation","volume":"269","author":"Sano","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.physiol.65.092101.142249","article-title":"Stress-activated cytokines and the heart: from adaptation to maladaptation","volume":"65","author":"Mann","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0170","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbadis.2019.01.020_bb0175","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/cvr\/cvy112","article-title":"Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: Roles of STAT3, interleukin 6 and hydrogen peroxide","volume":"114","author":"Loperena","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0180","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1074\/jbc.M110.162008","article-title":"Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter","volume":"286","author":"Wruck","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0185","article-title":"Prognostic significance of CD68, CD163 and folate receptor-\u03b2 positive macrophages in hepatocellular carcinoma","volume":"15","author":"Minami","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.112.300663","article-title":"Role of proinflammatory CD68(+) mannose receptor(\u2212) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans","volume":"33","author":"Boytard","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bbadis.2019.01.020_bb0195","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.bbrc.2017.09.149","article-title":"AKT2 deficiency induces retardation of myocyte development through EndoG-MEF2A signaling in mouse heart","volume":"493","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0200","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.yjmcc.2012.07.013","article-title":"Translation of myocyte enhancer factor-2 is induced by hypertrophic stimuli in cardiomyocytes through a calcineurin-dependent pathway","volume":"53","author":"Ye","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/nm789","article-title":"Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor","volume":"8","author":"Naya","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/eurjhf\/hft088","article-title":"Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders","volume":"15","author":"Marfella","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0215","doi-asserted-by":"crossref","DOI":"10.2217\/pgs.14.76","article-title":"Functional role of miRNA in cardiac resynchronization therapy","volume":"15","author":"Sardu","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7292564","article-title":"Cardiac resynchronization therapy outcomes in type 2 diabetic patients: role of microRNA changes","volume":"2016","author":"Sardu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-018-0778-9","volume":"17","author":"Sardu","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0230","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3389\/fphys.2018.01030","article-title":"Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: relationship with cardiac performance in overweight pre-diabetics patients","volume":"9","author":"Sardu","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0235","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2459\/01.JCM.0000253826.44234.09","article-title":"Effects of volume loading on strain rate and tissue Doppler velocity imaging in patients with idiopathic dilated cardiomyopathy","volume":"7","author":"Vicario","year":"2006","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0240","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fphys.2018.00758","article-title":"Stretch, injury and inflammation markers evaluation to predict clinical outcomes after implantable cardioverter defibrillator therapy in heart failure patients with metabolic syndrome","volume":"9","author":"Sardu","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008391","article-title":"Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes","volume":"4","author":"Ichikawa","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2008.10.007","article-title":"Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes","volume":"46","author":"He","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/hr.2011.175","article-title":"Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF","volume":"35","author":"Nako","year":"2012","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11906-017-0777-3","article-title":"Antihypertensive therapies and left ventricular hypertrophy","volume":"19","author":"Soliman","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0265","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.136655","article-title":"Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies","volume":"54","author":"Fagard","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0270","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ajh\/5.12.900","article-title":"Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system","volume":"5","author":"Dahlof","year":"1992","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0275","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","article-title":"Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies","volume":"275","author":"Schmieder","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2019.01.020_bb0280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lfs.2016.01.018","article-title":"Scutellarin protects cardiomyocyte ischemia\u2013reperfusion injury by reducing apoptosis and oxidative stress","volume":"157","author":"Wang","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/cvv028","article-title":"Impaired myocardial development resulting in neonatal cardiac hypoplasia alters postnatal growth and stress response in the heart","volume":"106","author":"Drenckhahn","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0290","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1074\/jbc.M510217200","article-title":"Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice","volume":"281","author":"Xu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0295","doi-asserted-by":"crossref","first-page":"42863","DOI":"10.1074\/jbc.M111.286880","article-title":"Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia","volume":"286","author":"Kweider","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0300","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1084\/jem.188.10.1955","article-title":"Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects","volume":"188","author":"Betz","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.0000134921.50377.61","article-title":"Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury","volume":"95","author":"Hilfiker-Kleiner","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2019.01.020_bb0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0092-8674(00)80729-1","article-title":"Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress","volume":"97","author":"Hirota","year":"1999","journal-title":"Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919300201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919300201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:34:16Z","timestamp":1777584856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919300201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0925443919300201"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.01.020","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6\/STAT3-dependent inflammation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}